John Porter

1.4k total citations
38 papers, 1.1k citations indexed

About

John Porter is a scholar working on Molecular Biology, Immunology and Allergy and Cancer Research. According to data from OpenAlex, John Porter has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 8 papers in Immunology and Allergy and 8 papers in Cancer Research. Recurrent topics in John Porter's work include Cell Adhesion Molecules Research (8 papers), Chemical Synthesis and Analysis (7 papers) and Protease and Inhibitor Mechanisms (6 papers). John Porter is often cited by papers focused on Cell Adhesion Molecules Research (8 papers), Chemical Synthesis and Analysis (7 papers) and Protease and Inhibitor Mechanisms (6 papers). John Porter collaborates with scholars based in United Kingdom, United States and Switzerland. John Porter's co-authors include Jean Rivier, Wylie Vale, Anne Corrigan, Catherine Rivier, Marilyn H. Perrin, James P. O’Connell, John Dykert, Reuben P. Siraganian, Ian Whitcombe and W. Alexander Van Hook and has published in prestigious journals such as Journal of the American Chemical Society, Nature Communications and Analytical Chemistry.

In The Last Decade

John Porter

38 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Porter United Kingdom 19 548 241 213 150 145 38 1.1k
J A Double United Kingdom 15 821 1.5× 191 0.8× 523 2.5× 374 2.5× 27 0.2× 29 1.7k
Warren S. Wade United States 15 788 1.4× 246 1.0× 166 0.8× 18 0.1× 67 0.5× 24 1.1k
Kevin P. Madauss United States 19 783 1.4× 162 0.7× 454 2.1× 62 0.4× 93 0.6× 28 1.6k
Judd Berman United States 20 852 1.6× 246 1.0× 353 1.7× 154 1.0× 6 0.0× 43 1.5k
Nigel J. Liverton United States 24 726 1.3× 711 3.0× 201 0.9× 56 0.4× 10 0.1× 61 1.8k
Ramesh Ummanni India 25 756 1.4× 494 2.0× 167 0.8× 231 1.5× 12 0.1× 64 1.6k
Jonathan S. Rosenblum United States 19 1.3k 2.4× 138 0.6× 392 1.8× 115 0.8× 14 0.1× 32 1.8k
Hardik Bhatt India 20 576 1.1× 361 1.5× 222 1.0× 245 1.6× 8 0.1× 64 1.3k
Kiyohiro Nishikawa Japan 21 767 1.4× 348 1.4× 397 1.9× 150 1.0× 9 0.1× 56 1.4k
Konstanty Wierzba Japan 19 1.2k 2.3× 420 1.7× 236 1.1× 104 0.7× 14 0.1× 35 1.7k

Countries citing papers authored by John Porter

Since Specialization
Citations

This map shows the geographic impact of John Porter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Porter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Porter more than expected).

Fields of papers citing papers by John Porter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Porter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Porter. The network helps show where John Porter may publish in the future.

Co-authorship network of co-authors of John Porter

This figure shows the co-authorship network connecting the top 25 collaborators of John Porter. A scholar is included among the top collaborators of John Porter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Porter. John Porter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lightwood, Daniel, John Porter, David McMillan, et al.. (2021). A conformation-selective monoclonal antibody against a small molecule-stabilised signalling-deficient form of TNF. Nature Communications. 12(1). 583–583. 22 indexed citations
2.
McMillan, David, C. Martinez-Fleites, John Porter, et al.. (2021). Structural insights into the disruption of TNF-TNFR1 signalling by small molecules stabilising a distorted TNF. Nature Communications. 12(1). 582–582. 63 indexed citations
3.
Porter, John, Yao Ding, Sarah Hale, et al.. (2020). A highly potent maytansinoid analogue and its use as a cytotoxic therapeutic agent in gold nanoparticles for the treatment of hepatocellular carcinoma. Bioorganic & Medicinal Chemistry Letters. 30(24). 127634–127634. 6 indexed citations
4.
O’Connell, James P., John Porter, Stephen Rapecki, et al.. (2019). Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimer. Nature Communications. 10(1). 5795–5795. 81 indexed citations
5.
Maple, Hannah J., Rachel A. Garlish, John Porter, et al.. (2011). Automated Protein–Ligand Interaction Screening by Mass Spectrometry. Journal of Medicinal Chemistry. 55(2). 837–851. 62 indexed citations
6.
Porter, John. (2010). Small molecule c-Met kinase inhibitors: a review of recent patents. Expert Opinion on Therapeutic Patents. 20(2). 159–177. 68 indexed citations
7.
Porter, John, Andrew Payne, Ian Whitcombe, et al.. (2009). Atropisomeric small molecule Bcl-2 ligands: Determination of bioactive conformation. Bioorganic & Medicinal Chemistry Letters. 19(6). 1767–1772. 28 indexed citations
8.
Porter, John, Simon Lumb, Richard J. Franklin, et al.. (2009). Discovery of 4-azaindoles as novel inhibitors of c-Met kinase. Bioorganic & Medicinal Chemistry Letters. 19(10). 2780–2784. 33 indexed citations
9.
Porter, John, Andrew Payne, Daniel Ford, et al.. (2008). Tetrahydroisoquinoline amide substituted phenyl pyrazoles as selective Bcl-2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(1). 230–233. 86 indexed citations
10.
Porter, John, David R. Critchley, John C. Head, et al.. (2002). N-(Pyrimidin-4-yl) and N-(Pyridin-2-yl) phenylalanine derivatives as VLA-4 integrin antagonists. Bioorganic & Medicinal Chemistry Letters. 12(12). 1595–1598. 5 indexed citations
11.
Porter, John, David R. Critchley, John C. Head, et al.. (2002). Discovery and evaluation of N-(triazin-1,3,5-yl) phenylalanine derivatives as VLA-4 integrin antagonists. Bioorganic & Medicinal Chemistry Letters. 12(12). 1591–1594. 25 indexed citations
12.
Head, John C., et al.. (2000). Discovery and evaluation of potent, cysteine-based α4β1 integrin antagonists. Bioorganic & Medicinal Chemistry Letters. 10(9). 993–995. 5 indexed citations
13.
Wang, Xiaoen, N. Willmott, Surinder K. Chander, et al.. (1997). Conversion of highly malignant colon cancer from an aggressive to a controlled disease by oral administration of a metalloproteinase inhibitor. Clinical & Experimental Metastasis. 15(2). 184–195. 48 indexed citations
14.
Rivier, J., Sabine L. Lahrichi, John Porter, et al.. (1996). Dose relationship between GnRH antagonists and pituitary suppression. Human Reproduction. 11(suppl 3). 133–147. 17 indexed citations
15.
Chander, Surinder K., Pari Antoniw, Nigel R. A. Beeley, et al.. (1995). An in Vivo Model for Screening Peptidomimetic Inhibitors of Gelatinase A. Journal of Pharmaceutical Sciences. 84(4). 404–409. 10 indexed citations
16.
Rivier, Jean, John Porter, Carl Hoeger, et al.. (1995). Gonadotropin-Releasing Hormone Antagonists: Novel Members of the Azaline B Family. Journal of Medicinal Chemistry. 38(14). 2649–2662. 52 indexed citations
17.
Lovejoy, David A., Anne Corrigan, Carol S. Nahorniak, et al.. (1995). Structural modifications of non-mammalian gonadotropin-releasing hormone (GnRH) isoforms: design of novel GnRH analogues. Regulatory Peptides. 60(2-3). 99–115. 15 indexed citations
18.
Craig, A. Grey, Steven C. Koerber, John Porter, Carl Hoeger, & Jean Rivier. (1993). An expanded nomenclature scheme for labeling peptide fragmentations and its use with ‘AMASS’, a computer program for generating all possible fragment ion structures from known precursors. Journal of Mass Spectrometry. 22(1). 31–44. 10 indexed citations
19.
Hoeger, Carl, et al.. (1989). Preparative-scale synthesis and reversed-phase purification of a gonadotropin-releasing hormone antagonist. Journal of Chromatography A. 484. 307–318. 6 indexed citations
20.
Porter, John, John Dykert, & Jean Rivier. (1987). Synthesis, resolution and characterization of ring substituted phenylalanines and tryptophans. International journal of peptide & protein research. 30(1). 13–21. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J A Double Breakdown of academic impact, for papers by Warren S. Wade Breakdown of academic impact, for papers by Kevin P. Madauss Breakdown of academic impact, for papers by Judd Berman Breakdown of academic impact, for papers by Nigel J. Liverton Breakdown of academic impact, for papers by Ramesh Ummanni Breakdown of academic impact, for papers by Jonathan S. Rosenblum Breakdown of academic impact, for papers by Hardik Bhatt Breakdown of academic impact, for papers by Kiyohiro Nishikawa Breakdown of academic impact, for papers by Konstanty Wierzba
Rankless by CCL
2026